Pleural effusion is associated with a poor treatment outcome in stage III small non-cleaved cell lymphoma.
The clinical significance of pleural effusion was assessed in 24 children with unresectable abdominal small non-cleaved cell lymphoma (St. Jude Stage III). Patients were consecutively enrolled and treated on a regimen including high dose fractionated cyclophosphamide and co-ordinated high dose methotrexate and cytarabine. The overall results were excellent, with 20 of 24 patients alive and event-free at a median follow-up of 4 years. Only one of the patients who lacked pleural effusion has relapsed (testicular), even though many had massive disease. In contrast, three of seven patients with pleural effusion have failed treatment (p = 0.02) and subsequently died. Two measures of tumor burden, serum lactic dehydrogenase and, in a subset of patients, interleukin-2-receptor levels, were significantly higher in patients with pleural effusion (p = 0.002 and p = 0.05, respectively). These findings suggest that unresectable abdominal small non-cleaved cell lymphoma associated with pleural effusion should be up-staged and that these patients should receive more intensive chemotherapy.
Sandlund
J T
JT
Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, TN 38101.
Crist
W M
WM
Abromowitch
M
M
Fairclough
D
D
Berard
C W
CW
Rafferty
M
M
Pui
C H
CH
D000008:Abdominal Neoplasms / Q000188:drug therapy*; D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D009367:Neoplasm Staging; D010996:Pleural Effusion / Q000188:drug therapy*; D015375:Receptors, Interleukin-2 / Q000097:blood
D015375:Receptors, Interleukin-2; D007770:L-Lactate Dehydrogenase